Literature DB >> 27648933

Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations.

Patricia Fergelot1, Martine Van Belzen2, Julien Van Gils3, Alexandra Afenjar4, Christine M Armour5, Benoit Arveiler1, Lex Beets6, Lydie Burglen4, Tiffany Busa7, Marie Collet8, Julie Deforges3, Bert B A de Vries9, Elena Dominguez Garrido10, Nathalie Dorison11, Juliette Dupont12, Christine Francannet13, Sixto Garciá-Minaúr14, Elisabeth Gabau Vila15, Samuel Gebre-Medhin16, Blanca Gener Querol17, David Geneviève18, Marion Gérard19, Cristina Giovanna Gervasini20, Alice Goldenberg21, Dragana Josifova22, Katherine Lachlan23, Saskia Maas6, Bruno Maranda24, Jukka S Moilanen25, Ann Nordgren26, Philippe Parent27, Julia Rankin28, Willie Reardon29, Marlène Rio7, Joëlle Roume30, Adam Shaw22, Robert Smigiel31, Amaia Sojo17, Benjamin Solomon32, Agnieszka Stembalska33, Constance Stumpel34, Francisco Suarez35, Paulien Terhal36, Simon Thomas37, Renaud Touraine38, Alain Verloes39, Catherine Vincent-Delorme40, Josephine Wincent26, Dorien J M Peters2, Oliver Bartsch41, Lidia Larizza42, Didier Lacombe1, Raoul C Hennekam6.   

Abstract

Rubinstein-Taybi syndrome (RSTS) is a developmental disorder characterized by a typical face and distal limbs abnormalities, intellectual disability, and a vast number of other features. Two genes are known to cause RSTS, CREBBP in 60% and EP300 in 8-10% of clinically diagnosed cases. Both paralogs act in chromatin remodeling and encode for transcriptional co-activators interacting with >400 proteins. Up to now 26 individuals with an EP300 mutation have been published. Here, we describe the phenotype and genotype of 42 unpublished RSTS patients carrying EP300 mutations and intragenic deletions and offer an update on another 10 patients. We compare the data to 308 individuals with CREBBP mutations. We demonstrate that EP300 mutations cause a phenotype that typically resembles the classical RSTS phenotype due to CREBBP mutations to a great extent, although most facial signs are less marked with the exception of a low-hanging columella. The limb anomalies are more similar to those in CREBBP mutated individuals except for angulation of thumbs and halluces which is very uncommon in EP300 mutated individuals. The intellectual disability is variable but typically less marked whereas the microcephaly is more common. All types of mutations occur but truncating mutations and small rearrangements are most common (86%). Missense mutations in the HAT domain are associated with a classical RSTS phenotype but otherwise no genotype-phenotype correlation is detected. Pre-eclampsia occurs in 12/52 mothers of EP300 mutated individuals versus in 2/59 mothers of CREBBP mutated individuals, making pregnancy with an EP300 mutated fetus the strongest known predictor for pre-eclampsia.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  EP300; Rubinstein-Taybi syndrome; genotype; phenotype; pre-eclampsia

Mesh:

Substances:

Year:  2016        PMID: 27648933     DOI: 10.1002/ajmg.a.37940

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  32 in total

1.  Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: the interconnections of epigenetic machinery disorders.

Authors:  Gloria Negri; Pamela Magini; Donatella Milani; Milena Crippa; Elisa Biamino; Maria Piccione; Stefano Sotgiu; Chiara Perrìa; Giuseppina Vitiello; Marina Frontali; Antonella Boni; Elisabetta Di Fede; Maria Chiara Gandini; Elisa Adele Colombo; Michael J Bamshad; Deborah A Nickerson; Joshua D Smith; Italia Loddo; Palma Finelli; Marco Seri; Tommaso Pippucci; Lidia Larizza; Cristina Gervasini
Journal:  Hum Genet       Date:  2019-02-26       Impact factor: 4.132

2.  A genotype-first approach identifies an intellectual disability-overweight syndrome caused by PHIP haploinsufficiency.

Authors:  Sandra Jansen; Alexander Hoischen; Bradley P Coe; Gemma L Carvill; Hilde Van Esch; Daniëlle G M Bosch; Ulla A Andersen; Carl Baker; Marijke Bauters; Raphael A Bernier; Bregje W van Bon; Hedi L Claahsen-van der Grinten; Jozef Gecz; Christian Gilissen; Lucia Grillo; Anna Hackett; Tjitske Kleefstra; David Koolen; Malin Kvarnung; Martin J Larsen; Carlo Marcelis; Fiona McKenzie; Marie-Lorraine Monin; Caroline Nava; Janneke H Schuurs-Hoeijmakers; Rolph Pfundt; Marloes Steehouwer; Servi J C Stevens; Connie T Stumpel; Fleur Vansenne; Mirella Vinci; Maartje van de Vorst; Petra de Vries; Kali Witherspoon; Joris A Veltman; Han G Brunner; Heather C Mefford; Corrado Romano; Lisenka E L M Vissers; Evan E Eichler; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2017-12-05       Impact factor: 4.246

Review 3.  Enhancers: bridging the gap between gene control and human disease.

Authors:  Jaret M Karnuta; Peter C Scacheri
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

4.  The core SWI/SNF catalytic subunit Brg1 regulates nephron progenitor cell proliferation and differentiation.

Authors:  Jeannine M Basta; Ajeet P Singh; Lynn Robbins; Lisa Stout; Michelle Pherson; Michael Rauchman
Journal:  Dev Biol       Date:  2020-06-03       Impact factor: 3.582

Review 5.  Rubinstein-Taybi Syndrome and Epigenetic Alterations.

Authors:  Edward Korzus
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

6.  Evaluation of Motor Skills in Children with Rubinstein-Taybi Syndrome.

Authors:  Jean René Cazalets; Emma Bestaven; Emilie Doat; Marie Pierre Baudier; Cécile Gallot; Anouck Amestoy; Manuel Bouvard; Etienne Guillaud; Isabelle Guillain; Emelyne Grech; Julien Van-Gils; Patricia Fergelot; Sonia Fraisse; Emmanuelle Taupiac; Benoit Arveiler; Didier Lacombe
Journal:  J Autism Dev Disord       Date:  2017-11

7.  Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity.

Authors:  Bradley P Coe; Holly A F Stessman; Arvis Sulovari; Madeleine R Geisheker; Trygve E Bakken; Allison M Lake; Joseph D Dougherty; Ed S Lein; Fereydoun Hormozdiari; Raphael A Bernier; Evan E Eichler
Journal:  Nat Genet       Date:  2018-12-17       Impact factor: 38.330

8.  Hyperinsulinism in an individual with an EP300 variant of Rubinstein-Taybi syndrome.

Authors:  K Taylor Wild; Tomoki T Nomakuchi; Sarah E Sheppard; Karla F Leavens; Diva D De León; Elaine H Zackai
Journal:  Am J Med Genet A       Date:  2021-01-14       Impact factor: 2.802

9.  Ultrasound 2-D and 3-D diagnosis of Rubinstein-Taybi syndrome in a 21-week-old fetus.

Authors:  Francesco D'Ambrosi; Luisa Ronzoni; Roberta Villa; Stefano De Marinis; Giulia Emily Cetera; Chiara Maria Soldavini; Enrico Ferrazzi
Journal:  J Ultrasound       Date:  2020-06-18

10.  Histone Deacetylase Inhibitors Ameliorate Morphological Defects and Hypoexcitability of iPSC-Neurons from Rubinstein-Taybi Patients.

Authors:  Valentina Alari; Paolo Scalmani; Paola Francesca Ajmone; Sara Perego; Sabrina Avignone; Ilaria Catusi; Paola Adele Lonati; Maria Orietta Borghi; Palma Finelli; Benedetta Terragni; Massimo Mantegazza; Silvia Russo; Lidia Larizza
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.